Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010802
Filing Date
2015-11-16
Accepted
2015-11-16 16:06:14
Documents
13
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cdtx-10q_20150930.htm 10-Q 1169453
2 EX-10.1 cdtx-ex101_378.htm EX-10.1 24952
3 EX-31.1 cdtx-ex311_8.htm EX-31.1 9250
4 EX-31.2 cdtx-ex312_6.htm EX-31.2 9495
5 EX-32.1 cdtx-ex321_9.htm EX-32.1 6459
6 EX-32.2 cdtx-ex322_7.htm EX-32.2 6319
7 GRAPHIC g201511161957295835701.jpg GRAPHIC 90837
  Complete submission text file 0001564590-15-010802.txt   4298810

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cdtx-20150930.xml EX-101.INS 693590
9 XBRL TAXONOMY EXTENSION SCHEMA cdtx-20150930.xsd EX-101.SCH 35002
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cdtx-20150930_cal.xml EX-101.CAL 30862
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdtx-20150930_def.xml EX-101.DEF 156867
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdtx-20150930_lab.xml EX-101.LAB 305376
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdtx-20150930_pre.xml EX-101.PRE 227272
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 151234366
SIC: 2836 Biological Products, (No Diagnostic Substances)